Aptorum Group Ltd. (NASDAQ: APM) Featured in Virtual Coverage of The Wall Street Investor Forum
Aptorum Group Ltd. (NASDAQ: APM) is a pharmaceutical company dedicated to developing and commercializing novel therapeutics to tackle unmet medical needs. Aptorum Group's current drug pipeline includes indications in orphan diseases, infectious diseases and metabolic diseases, a number of which are targeted to enter clinical trial phases. Aptorum Group is also launching a women's health supplement, dioscorea opposita bioactive nutraceutical tablets, marketed under the brand name NativusWell®. For more information, visit the company's website at www.aptorumgroup.com To register for The Wall Street Investor Forum and watch the live presentation, visit http://ibn.fm/TWSIFRegistration To view IBN’s virtual coverage of The Wall Street…







